Vaccines, Blood & Biologics
-
?
-
Workshops, Meetings & Conferences (Biologics)
FDA's Center for Biologics Evaluation and Research (CBER) sponsors or co-sponsors meetings, conferences and workshops about various biologics in order to educate the public and seek the opinion of interested parties. Minutes, transcripts, summaries and/or presentations for CBER sponsored or co-sponsored meetings and workshops are made available as soon after the meeting as possible.
Presentations are in chronological order, with the most recent event at the top of the list. Most will be removed after one year. If you want to keep the slides for future reference, they may be downloaded and saved. Slides that have been removed from the web site may be requested by submitting a written request to FDA's Freedom of Information staff.
-
Upcoming Workshops, Meetings & Conferences
Public Workshop - The Development and Evaluation of Human Cytomegalovirus Vaccines
January 10 and 11, 2012, Lister Hill Center Auditorium, National Institutes of Health, Bldg. 38A, 8600 Rockville Pike, Bethesda, MD 20894.Public Workshop - Data and Data Needs to Advance Risk Assessment for Emerging Infectious Diseases Relevant to Blood and Blood Products
November 29, 2011
-
-
CBER-Sponsored Workshops, Meetings & Conferences
Public Workshop - Hemoglobin Standards and Maintaining Adequate Iron Stores in Blood Donors
November 29, 2011Public Workshop - The Development and Evaluation of Next-Generation Smallpox Vaccines
September 16, 2011, Hilton Washington DC North/Gaithersburg, MD 20877Public Workshop - Quarantine Release Errors in Blood Establishments
September 13, 2011Risk Mitigation Strategies to Address Potential Procoagulant Activity in Immune Globulin Products
May 17-18, 2011; The Universities at Shady Grove Conference Center, Rockville, MD 20850Public Workshop - Study Methodologies for Diagnostics in the Postmarket Setting, May 12, 2011
May 12, 2011; FDA White Oak Campus, Silver Spring, MD, 20903Use of Functional Vision Endpoints in Visual Prostheses Product Development
May 6, 2011; Building 10, Masur Auditorium, National Institutes of Health, Bethesda, MDDIA/FDA CDER/CBER Computational Science Annual Meeting 
March 14-15, 2011; Sheraton National Hotel, Arlington, VAPluripotent Stem Cells in Translation: Early Decisions
March 21-22, 2011; Lister Hill Auditorium, Bethesda, MD 20892The 14th US-Japan Cellular and Gene Therapy Conference
February 24, 2011; Bethesda, Maryland 20892Determination of System Attributes for the Tracking and Tracing of Prescription Drugs; Public Workshop
February 15-16, 2011; Silver Spring, MD 20993Public Workshop: Product Development Program for Interventions in Patients with Severe Bleeding Due to Trauma or Other Causes
December 9-10, 2010; Bethesda, MD 20892Public Meeting on Animal Models—Essential Elements to Address Efficacy Under the Animal Rule; and Reopening of Comment Period
November 5, 2010; Silver Spring, MDPublic Workshop on Cell and Gene Therapy Clinical Trials in Pediatric Populations
November 2, 2010; North Bethesda, MDQuantitative Risk Assessment: Blood Safety and Availability Public Workshop May 13, 2010; Gaithersburg, MD Emerging Infectious Diseases: Evaluation to Implementation for Transfusion and Transplantation Safety Public Workshop May 11 -12, 2010; Gaithersburg, MD DIA/FDA CDER/CBER Computational Science Annual Meeting March 22 - 23, 2010; Bethesda, MD Cord Blood Licensure: A Workshop March 8 - 9, 2010; Rockville, MD Public Workshop: Emerging Arboviruses: Evaluating the Threat to Transfusion and Transplantation Safety December 14-15, 2009 Blood Establishment Computer Software: Understanding What to Include in a 510(k) Submission; Public Workshop November 4-5, 2009 FDA-NCI Workshop on Therapeutic Cancer Vaccines October 27, 2009 Public Workshop: FDA Regulation and Licensure of Whole Blood and Blood Components September 15 - 16, 2009 Public Workshop: Adjuvants and Adjuvanted Preventative and Therapeutic Vaccines for Infectious Disease Indications December 2 - 3, 2008 Rapid Methods for Detecting Mycoplasma Contamination in the Manufacture of Vaccines, Including Pandemic Influenza Vaccines, and Other Biological Products September 22 - 23, 2008 Public Workshop: Animal Models for the Treatment of Acute Radiation Syndrome
September 17-18, 2008Public Workshop: Safety of Hemoglobin-Based Oxygen Carriers (HBOCs) April 29 - 30, 2008 FDA/NIH/WHO Public Workshop: Immune Correlates of Protection Against Influenza A Viruses in Support of Pandemic Vaccine Development December 10 - 11, 2007 FDA/NIST Sponsored Workshop: In Vitro Analyses of Cell/Scaffold Products December 6 - 7, 2007 Improving Endpoints, Improving Care: Alpha-1 Antitrypsin Augmentation Therapy and Clinical Trials; Public Workshop March 23 - 24, 2009 Public Workshop: America's Blood Centers: Blood Establishment Computer Software (BECS) Conference July 10 - 11, 2008 Bar Code Requirements for Blood Banks January 20, 2006 Bar Code Label Requirements for Blood and Blood Components May 10, 2006 FDA Workshop on Testing for Malarial Infections in Blood Donors July 12, 2006
-
-
Other Workshops and Presentations
Two-day Tissue Adhesives / Soft Tissue Workshop / Symposium, September 26-27, 2011
September 26-27, 2011, FDA White Oak Campus, Building 2, Silver Spring, MarylandFDA Clinical Investigator Training Course
November 7-9, 2011, Silver Spring, MD13th International Paul-Ehrlich-Seminar - Allergen Products for Diagnosis and Therapy: Regulation and Science
September 14-17, 2011; Hyatt Regency Washington on Capitol HillNHLBI PACT Workshop: Cell Therapy for Pediatric Diseases: A Growing Frontier
September 14-15, 2011; National Library of Medicine, Lister Hill Center Auditorium, National Institutes of Health- Safety and Efficacy of Hypnotic Drugs: An FDA-PERI co-sponsored workshop
May 10-11, 2011; Bethesda Marriott, Bethesda, MD FDA Clinical Trial Requirements, Regulations, Compliance and GCP
May 4-5, 2011, Denver, ColoradoTranslational Regenerative Medicine Forum
April 6-9, 2011, Washington, DC- Regulatory Affairs Professional Society (RAPS) Annual Conference
October 24-27, 2010; San Jose, California International Workshop on Alternative Methods to Reduce, Refine, and Replace the Use of Animals in Vaccine Potency and Safety Testing: State of the Science and Future Directions
September 14-16, 2010, Bethesda, MDActing Director for the Office of Orphan Products
FDA White Oak Campus, Silver Spring, Maryland, June 29-30, 2010.Risk Evaluation and Mitigation Strategy (REMS) Public Meeting
July 27-28, 2010; Silver Spring, MarylandNew York Academy of Sciences Meeting on Probiotics
June 2010Vaccine Safety Webinar
July 13, 2010ISSCR/CIRM/ISCT Workshop
June 15, 2010Probiotics: from Bench to Market
June 11, 2010MPCC Seminar Series April 6, 2010 Medical Research Center's (NMRC) Malaria Vaccine Development Program February 25, 2010 6th Annual Tissue Conference
February 3-5, 2010Pharma Conference
January 27-29, 2010Phacilitate Cell and Gene Therapy Forum January 2010 Mid-Atlantic Bio
November 6, 2009Third Annual HD Clinical Research Symposium
November 21, 2009Fourth Annual Translational Stem Cell Research Conference
October 13, 2009AABB Annual Meeting
October 2009Regulatory Affairs Professionals Society (RAPS) Annual Conference and Exhibition
September 13-16, 2009American Association of Tissue Banks (AATB) Spring Meeting March 28, 2009 5th Annual FDA and the Changing Paradigm for HCT/P Regulation
January 28, 200912th Annual FDA and the Changing Paradigm for Blood Regulation January 14-16, 2009 CDISC International Interchange October 30, 2008 International Conference of Drug Regulatory Authorities (ICDRA) Conference September 19, 2008 PDA/FDA Joint Meeting September 9-10, 2008 Good Manufacturing Practices (GMP) by the Sea Meeting August 27, 2008 BIO International Convention June 17-20, 2008 American Society of Clinical Oncology June 2, 2008 Society of Clinical Research Associates (SoCRA) May 22-23, 2008 Infectious Disease Society of America (IDSA) May 19, 2008 How Fast Can a New Vaccine for an Emerging Respiratory Virus Be Developed and Available For Use? (PDF - 903KB)March 22, 2006
-
?
?
-
Contact FDA
(800) 835-4709
(301) 827-1800
Consumer Affairs Branch (CBER)
Division of Communication and Consumer Affairs
Office of Communication, Outreach and Development
Food and Drug Administration
1401 Rockville Pike
Suite 200N/HFM-47
Rockville, MD 20852-1448
-
-
